QUICKLINKS AND VIEW OPITONS
Low cholesterol levels are dangerous, high ones usually are not, Joel Kauffman, PhD
Thursday, November 03, 2011 12:14 pm Email this article
The basis for using cholesterol-lowering drugs is not based on science notes Joel M. Kauffman, PhD, the author of Malignant Medical Myths: Why Medical Treatment Causes 200,000 Deaths in the USA each Year, and How to Protect Yourself.
"Low cholesterol levels are dangerous; high ones usually are not," Kauffman writes. Cholesterol Levels Increase Naturally With Age
Cholesterol levels increase naturally with age probably to protect us
“Cholesterol levels increase naturally with age, probably as a defense mechanism against inflammation and cancer.
Statins of Little Benefit
Statins of little benefit, but have debilitating side effects
“Clinical trials (RCTs) of statin drugs indicate no worthwhile overall benefit for primary prevention of heart attacks, but high risk of debilitating side-effects.
“Trials on secondary prevention [ that is, involving people who have already had a heart attack] indicate very minor benefits on the order of what might have been obtained from Bufferin [aspirin to prevent a second heart attack], and the benefits are unrelated to the achieved cholesterol levels.
Any Benefit of Statins Has Nothing to Do with Lowering Cholesterol
Any benefit of statins has nothing to do with lowering cholesterol
“In hospitalized men with [cardiovascular disease]... the minor benefits of statin drugs have nothing to do with lowering serum cholesterol levels.
Statins Provide Little Benefit in Men, and NO Benefit in Women
Statins provide little benefit in men, and NO benefit in women
“It is unlikely that the adverse-effect-prone statin drugs are of any overall benefit in men, and certainly not in women.
There Is No Reason To Lower Cholesterol
There is no reason to lower cholesterol with drugs or alternative treatments
“Any hype for alternative cholesterol-lowering treatments indicates a complete fraud since there is no reason for lowering cholesterol levels.”
Kauffman’s Journey Began in 1999
In 1999, Kauffman’s started researching the truth about aspirin
Kauffman notes that:
“Beginning in 1999 the conflict between recommendations on long-term use of aspirin to prevent heart attacks was so striking that I dug into the medical journals to find out the truth about aspirin.
“The result became Myth One in my book Malignant Medical Myths: Why Medical Treatment Causes 200,000 Deaths in the USA each Year, and How to Protect Yourself.
Until 1990, Kauffman Believed the Medical Literature and Diet Advice
Until 1990, Kauffman believed the medical literature and diet advice, believing that most medical and diet advice was reliable
Early, Kaufmann noted that:
“Until about 1990, like most people, Kauffman believed that most medical and diet advice was reliable, especially from government agencies we pay so much to take care of us.
Until 1990, Kauffman Took a Baby Aspirin, Had is Cholesterol Measured, Etc
Until 1990, Kauffman took a baby aspirin, had is cholesterol measured, drank fluoridated water, etc, believing that medical journal articles were honest and complete
“He took baby aspirin, ate trans fat, drank fluoridated water and had his cholesterol measured in the belief that others were looking out for us by basing their recommendations on the best evidence from trials.
“When medical brochures and advertisements referred to papers in peer-reviewed medical journals, I assumed that these papers were honest and complete, based on my own experience as the author of 80 journal papers myself, which were subject to rigorous peer review.
Medical Abstracts Often Incomplete and Misleading
Kauffman found that medical abstracts were often incomplete and misleading, often leaving out all-cause mortality and side-effects
Kauffman goes on to say:
“Determined to understand medical papers, Kauffman struggled with jargon and slowly caught onto the tricks of the trade, such as incomplete and misleading abstracts.
“The abstract of a paper is supposed to summarize the purpose, choice of subjects, trial protocol, and results.
When Abstracts Are Incomplete, This Information is Left Out of Media Stories
When abstracts do not mention all-cause mortality and side-effects, the media never does not include this in their coverage
“When key results are left out of the abstract, such as all-cause mortality and side-effects, they remain left out of any press release, newspaper article and sales literature.
When The Whole Paper Is Examined, Shocking Cover Ups Come To Light
When the whole paper is examined, shocking cover ups come to light such as excess cancer deaths
He continues, saying:
“When the whole paper is examined, shocking cover ups come to light, in many cases, such as excess cancer deaths even when some easily measurable stuff, like cholesterol, is lowered, which is supposed to be a benefit, but is not.
“People who would most benefit from a diet intervention are often excluded from the chosen subjects.
High Dropout Rates Often Left Out of Abstracts
Very high dropout rates due to drug side-effects usually left out of abstracts
“Very high dropout rates because of treatment side-effects usually do not find their way to the abstract.
This myth his from an article by Kauffman
This medical myth is from an article by Joel Kauffman posted on the very interesting website SpaceDoc.com in an article titled Malignant Medical Myths in which he briefly describes the eleven (11) medical myths he writes about in his book.
Other Kauffman articles
Other Kauffman articles are posted here
Other articles by Joel Kauffman, PhD are posted here:
- Typical background radiation is not only harmless, but actually beneficial notes Joel Kaufmann, PhD
- EDTA chelation retards or reverses atherosclerosis notes Joel Kaufmann, PhD
- Extreme exercise can cause heart failure and other injuries notes Joel Kaufmann, PhD
- No proof that red wine reduces the risk of death notes Joel Kaufmann, PhD
- Low cholesterol levels are dangerous, high ones usually are not, Joel Kaufmann, PhD
- Advice to eat diets low in saturated fat and cholesterol are not based on science, Joel Kaufmann PhD
- Daily aspirin does not reduce mortality in men, and increases mortality in women, Joel Kaufmann, PhD
- Statins INCREASE the risk of dying by 1% over 10 years
Joel M. Kauffman, PhD
Professor of Chemistry Emeritus
University of the Sciences of Philadelphia
65 Meadowbrook Rd
Wayne, PA 19087-2510 USA
(215) 596-8839 phone
About Joel Kauffman, PhD
Joel Kauffman, PhD is Professor of Chemistry Emeritus from the University of the Sciences of Philadelphia, Pennsylvania.
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.